STOCKWATCH
·
Specialty Chemicals
Acquisitions29 Sept 2025, 07:42 pm

Camlin Fine Sciences to Acquire Majority Stake in Vinpai for INR 101.7 Crores via Share Swap

AI Summary

Camlin Fine Sciences Ltd announced the outcome of its Board Meeting held on September 29, 2025. The Board approved a preferential issue of up to 41,06,181 fully paid-up equity shares at a price of INR 247.69 per share, amounting to INR 101,70,59,971.89, for the acquisition of ordinary shares of Vinpai, a French société anonyme. The acquisition will be carried out through a share swap arrangement, as per the terms of the share purchase agreement dated February 24, 2025, and amendments thereof. This move will result in Camlin Fine Sciences acquiring approximately 78.68% of Vinpai's outstanding share capital.

Key Highlights

  • Camlin Fine Sciences to acquire a majority stake in Vinpai for INR 101.7 Crores.
  • The acquisition will be carried out through a share swap arrangement.
  • The Board approved a preferential issue of 41,06,181 equity shares at INR 247.69 per share.
  • The acquisition will result in Camlin Fine Sciences owning approximately 78.68% of Vinpai's outstanding share capital.
  • The decision is subject to statutory/regulatory approval and shareholder approval.
CAMLINFINE
Specialty Chemicals
CAMLIN FINE SCIENCES LTD.

Price Impact